THE PREDISPOSITION FOR TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME
Zenoaga-Barbăroșie C, Berca L, Vassu-Dimov T, Toma M, Nica MI, Alexiu-Toma OA, Ciornei C, Albu A, Nica S, Nistor C, Nica R
*Corresponding Author: Corresponding Author: Ass. Prof. Silvia Nica MD, PhD, Bucharest Emergency University Hospital, Splaiul Independentei Street, no 169, 5 District, Bucharest, Romania, 050098 Tel.: +40-21-31880500, email: silvia.nica@umfcd.ro
page: 21
|
|
REFERENCES
1. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova
K, Duncan BB, et al. IDF Diabetes Atlas: Global,
regional and country-level diabetes prevalence estimates
for 2021 and projections for 2045. Diabetes
Res Clin Pract. 2022;183:109119.
2. Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, Nkeck
JR, Nyaga UF, Ngouo AT, et al. Geographic distribution
of metabolic syndrome and its components in the
general adult population: A meta-analysis of global
data from 28 million individuals. Diabetes Res Clin
Pract. 2022;188:109924.
3. Kahn SE, Cooper ME, Del Prato S. Pathophysiology
and treatment of type 2 diabetes: perspectives
on the past, present, and future. Lancet.
2014;383(9922):106883.
4. Bellou V, Belbasis L, Tzoulaki I, Evangelou E. Risk
factors for type 2 diabetes mellitus: An exposurewide
umbrella review of meta-analyses. PLoS One.
2018;13(3):e0194127.
5. Damiri B, Badran L, Safadi D, Sawalha A, Yasin Y,
Sawalha M, et al. Metabolic syndrome and related
risk factors among adults in the northern West Bank, a
cross-sectional study. Int Health. 2022;14(4):33945.
6. Tavares AM, Silva JH, Bensusan C de O, Ferreira
ACF, Matos LP de L, e Souza KL de A, et al.
Altered superoxide dismutase-1 activity and intercellular
adhesion molecule 1 (ICAM-1) levels in
patients with type 2 diabetes mellitus. PLoS One.
2019;14(5):e0216256.
7. Hebert-Schuster M, Fabre EE, Nivet-Antoine V. Catalase
polymorphisms and metabolic diseases. Curr
Opin Clin Nutr Metab Care. 2012;15(4):397402.
8. Raina P, Sikka R, Gupta H, Matharoo K, Bali SK,
Singh V, et al. Association of eNOS and MCP-1 Genetic
Variants with Type 2 Diabetes and Diabetic Nephropathy
Susceptibility: A Case-Control and Meta-
Analysis Study. Biochem Genet. 2021;59(4):96696.
9. Stephens JW, Dhamrait SS, Cooper JA, Acharya J,
Miller GJ, Hurel SJ, et al. The D allele of the ACE
I/D common gene variant is associated with Type 2
diabetes mellitus in Caucasian subjects. Mol Genet
Metab. 2005;84(1):839.
10. Xi B, Ruiter R, Chen J, Pan H, Wang Y, Mi J. The
ACE insertion/deletion polymorphism and its association
with metabolic syndrome. Metabolism.
2012;61(6):8917.
11. Alavi-Shahri J, Behravan J, Hassany M, Tatari F,
Kasaian J, Ganjali R, et al. Association between
angiotensin II type 1 receptor gene polymorphism
and metabolic syndrome in a young female Iranian
population. Arch Med Res. 2010;41(5):3439.
12. Hou L, Quan X, Li X, Su X. Correlation between gene
polymorphism in angiotensin II type 1 receptor and
type 2 diabetes mellitus complicated by hypertension
in a population of Inner Mongolia. BMC Med Genet.
2020;21(1):83.
13. Saravani R, Esmaeeli E, Kordi Tamendani M, Nejad
MN. Oxytocin Receptor Gene Polymorphisms
in Patients With Diabetes. Gene, Cell Tissue.
2015;2(2):e60171.
14. Winterton A, Bettella F, de Lange A-MG, Haram
M, Steen NE, Westlye LT, et al. Oxytocin-pathway
polygenic scores for severe mental disorders and
metabolic phenotypes in the UK Biobank. Transl
Psychiatry. 2021;11(1):599.
15. Kautzky-Willer A, Harreiter J, Pacini G. Sex and
Gender Differences in Risk, Pathophysiology and
Complications of Type 2 Diabetes Mellitus. Endocr
Rev. 2016;37(3):278316.
16. Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender
differences in the metabolic syndrome and their
role for cardiovascular disease. Clin Res Cardiol.
2006;95(3):13647.
17. Chamberlain JJ, Rhinehart AS, Shaefer CFJ, Neuman
A. Diagnosis and Management of Diabetes: Synopsis
of the 2016 American Diabetes Association Standards
of Medical Care in Diabetes. Ann Intern Med.
2016;164(8):54252.
18. Akcay A, Sezer S, Ozdemir FN, Arat Z, Atac FB,
Verdi H, et al. Association of the genetic polymorphisms
of the renin-angiotensin system and endothelial
nitric oxide synthase with chronic renal transplant
dysfunction. Transplantation. 2004;78(6):8928.
19. Truzzi A, Poquérusse J, Setoh P, Shinohara K, Bornstein
MH, Esposito G. Oxytocin receptor gene polymorphisms
(rs53576) and early paternal care sensitize
males to distressing female vocalizations. Dev
Psychobiol. 2018;60(3):3339.
20. Saygi S, Erol İ, Alehan F, Yalçın YY, Kubat G, Ataç
FB. Superoxide Dismutase and Catalase Genotypes
in Pediatric Migraine Patients. J Child Neurol.
2015;30(12):158690.
21. Volpe CMO, Villar-Delfino PH, Dos Anjos PMF,
Nogueira-Machado JA. Cellular death, reactive oxygen
species (ROS) and diabetic complications. Cell
Death Dis. 2018;9(2):119.
22. Lewandowski Ł, Kepinska M, Milnerowicz H. Alterations
in Concentration/Activity of Superoxide
Dismutases in Context of Obesity and Selected Single
Nucleotide Polymorphisms in Genes: SOD1, SOD2,
SOD3. Int J Mol Sci. 2020;21(14):5069
23. Panduru NM, Cimponeriu D, Cruce M, Ion DA, Moţa
E, Moţa M, et al. Association of +35A/C (intron3/
exon3) polymorphism in SOD1-gene with diabetic
nephropathy in type 1 diabetes. Rom J Morphol Embryol.
2010;51(1):3741.
24. Flekac M, Skrha J, Hilgertova J, Lacinova Z, Jarolimkova
M. Gene polymorphisms of superoxide dismutases
and catalase in diabetes mellitus. BMC Med
Genet. 2008;9:30.
25. Lewandowski Ł, Urbanowicz I, Kepinska M, Milnerowicz
H. Concentration/activity of superoxide dismutase
isozymes and the pro-/antioxidative status, in context of
type 2 diabetes and selected single nucleotide polymorphisms
(genes: INS, SOD1, SOD2, SOD3) - Preliminary
findings. Biomed Pharmacother. 2021;137:111396.
26. El Alami H, Ghazal H, Abidi O, Al Idrissi N, Wakrim
L, Naamane A, et al. Relationship between insertion/
deletion (I/D) polymorphism of angiotensin converting
enzyme (ACE) gene and susceptibility to type 2
diabetes mellitus in the Middle East and North Africa
Region: A meta-analysis. Diabetes Metab Syndr.
2022;16(1):102386.
27. Zarouk WA, Hussein IR, Esmaeil NN, Raslan HM,
Reheim HAA, Moguib O, et al. Association of angio
tensin converting enzyme gene (I/D) polymorphism
with hypertension and type 2 diabetes. Bratisl Lek
Listy. 2012;113(1):148.
28. Ramachandran V, Ismail P, Stanslas J, Shamsudin N,
Moin S, Mohd Jas R. Association of insertion/deletion
polymorphism of angiotensin-converting enzyme
gene with essential hypertension and type 2 diabetes
mellitus in Malaysian subjects. J Renin Angiotensin
Aldosterone Syst. 2008;9(4):20814.
29. Zhou L, Xue Y, Luo R, Gao F. [Association of
insertion/deletion polymorphism in angiotensinconverting
enzyme gene with hypertensive type 2
diabetes mellitus]. Di Yi Jun Yi Da Xue Xue Bao.
2002;22(9):80810.
30. Araz M, Aynacioglu S, Aktaran S, Alasehirli B, Okan
V. Association between polymorphism of the angiotensin
I converting enzyme gene and hypertension in
Turkish type II diabetic patients. Acta medica(Hradec
Kralove). 2001;44(1):29-32.
31. Alsafar H, Hassoun A, Almazrouei S, Kamal W,
Almaini M, Odama U, et al. Association of Angiotensin
Converting Enzyme Insertion-Deletion Polymorphism
with Hypertension in Emiratis with Type
2 Diabetes Mellitus and Its Interaction with Obesity
Status. Dis Markers. 2015;2015:536041.
32. Ahmad N, Jamal R, Shah SA, Gafor AHA, Murad
NAA. Renin-Angiotensin-Aldosterone System Gene
Polymorphisms and Type 2 Diabetic Nephropathy in
Asian Populations: An Updated Meta-analysis. Curr
Diabetes Rev. 2019;15(4):26376.
33. Al-Rubeaan K, Siddiqui K, Saeb ATM, Nazir N, Al-
Naqeb D, Al-Qasim S. ACE I/D and MTHFR C677T
polymorphisms are significantly associated with type
2 diabetes in Arab ethnicity: A meta-analysis. Gene.
2013;520(2):16677.
34. Niu W, Qi Y, Gao P, Zhu D. Angiotensin converting
enzyme D allele is associated with an increased risk
of type 2 diabetes: evidence from a meta-analysis.
Endocr J. 2010;57(5):4318.
35. Jalil JE, Córdova S, Ocaranza M a, Schumacher E,
Braun S, Chamorro G, et al. Angiotensin I-converting
enzyme insertion/deletion polymorphism and adrenergic
response to exercise in hypertensive patients.
Med Sci Monit. 2002;8(8):CR566-71.
36. Srinivasa S, Aulinas A, OMalley T, Maehler P, Adler
GK, Grinspoon SK, et al. Oxytocin response to controlled
dietary sodium and angiotensin II among
healthy individuals. Am J Physiol Endocrinol Metab.
2018;315(4):E6715.
37. Bealer SL, Crowley WR. Angiotensin II-induced
release of oxytocin: interaction with norepinephrine
and role in lactation. Regul Pept. 2003;111(1):416.
38. Dietze GJ, Henriksen EJ. Angiotensin-converting
enzyme in skeletal muscle: sentinel of blood pressure
control and glucose homeostasis. J Renin Angiotensin
Aldosterone Syst. 2008;9(2):7588.
39. McQuaid RJ, McInnis OA, Matheson K, Anisman H.
Distress of ostracism: oxytocin receptor gene polymorphism
confers sensitivity to social exclusion. Soc
Cogn Affect Neurosci. 2015;10(8):11539.
40. Chang HH, Chang WH, Chi MH, Peng YC, Huang
C-C, Yang YK, et al. The OXTR Polymorphism
Stratified the Correlation of Oxytocin and Glucose
Homeostasis in Non-Diabetic Subjects. Diabetes Metab
Syndr Obes. 2019;12:270713.
41. Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra
J, Mohapatra S, et al. Alcohol as a risk factor for type
2 diabetes: A systematic review and meta-analysis.
Diabetes Care. 2009;32(11):212332.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
